Visualizing oxidative stress using hyperpolarized magnetic resonance
使用超极化磁共振可视化氧化应激
基本信息
- 批准号:10612868
- 负责人:
- 金额:$ 64.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAgingAnimal ModelAntioxidantsAscorbic AcidBiochemical ReactionBiomedical EngineeringBlood - brain barrier anatomyBrainBrain NeoplasmsCancer BiologyCell DeathCellsCellular StressChemicalsChemotherapy and/or radiationClinicalDNA DamageDataDetectionDevelopmentDiseaseDoseEnvironmentEquilibriumFaceFeasibility StudiesFoundationsFutureGenerationsGlycolysisGoalsHomeostasisHumanImageImaging technologyIn VitroIsotopesLearningLiquid substanceMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMeasurementMeasuresMetabolicMetabolic PathwayMetabolismMethodsMolecular ProbesMonitorMotivationMusNerve DegenerationNeurodegenerative DisordersOxidantsOxidation-ReductionOxidative StressPathogenesisPathologyPatientsPhysical ChemistryPlayPre-Clinical ModelProcessPyruvateRadiationRadiation therapyReactive Oxygen SpeciesRelaxationResearchResearch ProposalsRoleSignal TransductionSignaling MoleculeSolidSystemTherapeuticTimeTissuesToxicologyTranslatingTranslationsTransport ProcessVisualizationWorkascorbateblood-brain barrier crossingbrain tumor imagingcancer therapyclinical translationdehydroascorbatedesigndocosahexaenoylascorbic acidexperiencefirst-in-humanhuman imagingimaging approachimaging modalityin vivoindividualized medicineinnovationmetabolic abnormality assessmentmetabolic imagingmolecular imagingmouse modelnon-invasive imagingnon-invasive monitornovelnovel strategiesoxidationpreclinical studysmall moleculespectroscopic imagingstandard of caretranslation to humanstreatment planningtreatment response
项目摘要
PROJECT SUMMARY/ABSTRACT
Reactive oxygen species (ROS) are the byproduct of normal metabolism as well as the differential state and
environment of the cell. They lead to oxidative stress and can be the causes of multiple pathologies, including
cancer. Moreover, oxidative stress and the cell's ability to deal with it can play a major role in the treatment of
these diseases. However, current methods to quantify oxidative stress in vivo are severely lacking and to date
there is no routine method to non-invasively image redox or oxidative stress in humans.
A new platform, hyperpolarized MRI, has the potential to change the way we interrogate metabolism in vivo. We
and others have utilized the power of this approach, combined with endogenous substrates, to non-invasively
image a metabolic substrate and its subsequent downstream products using conventional MRI. In our preliminary
work, we have developed a novel approach to imaging oxidative stress using HP dehydroascorbate (HP DHA),
the oxidized form of vitamin C. Using HP DHA, we are able to image the in vivo generation of HP vitamin C and
utilize the cells' endogenous system to create a non-invasive redox measurement. Combining this with fast
spectroscopic imaging approaches provides a means of readily imaging redox in mice.
These exciting developments provide the basis for pursuing the objectives of this innovative proposal to utilize HP
DHA MRI to further quantify oxidative stress in vivo. Using HP DHA, we will develop a parameter for conversion to
Vitamin C in vivo that quantifies the amount of oxidative stress the cell is under using both acute generation of
ROS in the normal brain and models of murine brain tumors treated with radiation. In parallel, we will utilize what
we have recently learned about the physical chemistry of hyperpolarized probes to design a more robust and
better performing HP DHA. Finally, we will conduct the optimization and toxicology studies necessary to translate
HP DHA to humans, aiming to conduct the first-in-human studies of this approach.
It is the overarching goal of this proposal to use this novel approach in metabolic imaging and lay the foundation
for future metabolic imaging of oxidative stress in patients. This effort will also provide a means of non-invasively
monitoring treatment response that aims to increase oxidative stress, which could be readily integrated into
standard MRI.
项目总结/摘要
活性氧(ROS)是正常代谢的副产物,也是细胞内的差异状态,
细胞的环境。它们会导致氧化应激,并可能导致多种病理,包括
癌此外,氧化应激和细胞处理它的能力可以在治疗中发挥重要作用。
这些疾病。然而,目前的方法来量化体内氧化应激是严重缺乏和日期
没有常规方法对人体的氧化还原或氧化应激进行非侵入性成像。
一个新的平台,超极化MRI,有可能改变我们询问体内代谢的方式。我们
和其他人已经利用这种方法的力量,结合内源性底物,
使用常规MRI对代谢底物及其后续下游产物进行成像。在我们的初步调查中
工作,我们已经开发了一种新的方法来成像氧化应激使用HP脱氢抗坏血酸(HP DHA),
维生素C的氧化形式。使用HP DHA,我们能够成像HP维生素C和维生素D的体内生成。
利用细胞的内源性系统来创建非侵入性氧化还原测量。结合快速
光谱成像方法提供了一种容易对小鼠中的氧化还原进行成像的方法。
这些令人兴奋的发展为实现这一创新提案的目标提供了基础,
DHA MRI进一步量化体内氧化应激。使用HP DHA,我们将开发一个转换参数,
维生素C在体内定量的氧化应激的细胞是在使用两个急性代,
放射治疗的正常脑和小鼠脑肿瘤模型中的ROS。同时,我们将利用
我们最近已经了解了超极化探针的物理化学,以设计更坚固和
更好地执行HP DHA。最后,我们将进行必要的优化和毒理学研究,
HP DHA用于人类,旨在进行这种方法的首次人体研究。
这项提案的首要目标是在代谢成像中使用这种新方法,
用于未来患者氧化应激的代谢成像。这项工作还将提供一种非侵入性的手段,
监测治疗反应,旨在增加氧化应激,这可以很容易地整合到
标准MRI。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells.
- DOI:10.1016/j.cmet.2020.12.005
- 发表时间:2021-01-05
- 期刊:
- 影响因子:29
- 作者:Jeong S;Savino AM;Chirayil R;Barin E;Cheng Y;Park SM;Schurer A;Mullarky E;Cantley LC;Kharas MG;Keshari KR
- 通讯作者:Keshari KR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kayvan R Keshari其他文献
Kayvan R Keshari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kayvan R Keshari', 18)}}的其他基金
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging
使用代谢成像研究体内氧化应激诱导的白血病程序
- 批准号:
10729140 - 财政年份:2023
- 资助金额:
$ 64.67万 - 项目类别:
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
图像引导 Trp-IDO/TDO-Kyn-AHR 通路抑制结合免疫治疗
- 批准号:
10600027 - 财政年份:2021
- 资助金额:
$ 64.67万 - 项目类别:
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
图像引导 Trp-IDO/TDO-Kyn-AHR 通路抑制结合免疫治疗
- 批准号:
10721993 - 财政年份:2021
- 资助金额:
$ 64.67万 - 项目类别:
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
利用果糖运输创造一种特殊底物来选择性地为 T 细胞提供燃料
- 批准号:
10529307 - 财政年份:2020
- 资助金额:
$ 64.67万 - 项目类别:
Visualizing oxidative stress using hyperpolarized magnetic resonance
使用超极化磁共振可视化氧化应激
- 批准号:
10037873 - 财政年份:2020
- 资助金额:
$ 64.67万 - 项目类别:
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
利用果糖运输创造一种特殊底物来选择性地为 T 细胞提供燃料
- 批准号:
10318220 - 财政年份:2020
- 资助金额:
$ 64.67万 - 项目类别:
Visualizing oxidative stress using hyperpolarized magnetic resonance
使用超极化磁共振可视化氧化应激
- 批准号:
10162569 - 财政年份:2020
- 资助金额:
$ 64.67万 - 项目类别:
Visualizing oxidative stress using hyperpolarized magnetic resonance
使用超极化磁共振可视化氧化应激
- 批准号:
10402394 - 财政年份:2020
- 资助金额:
$ 64.67万 - 项目类别:
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery
用于生物标志物发现的人体组织培养生物反应器和超极化 MR
- 批准号:
8691806 - 财政年份:2013
- 资助金额:
$ 64.67万 - 项目类别:
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery
用于生物标志物发现的人体组织培养生物反应器和超极化 MR
- 批准号:
8670990 - 财政年份:2013
- 资助金额:
$ 64.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 64.67万 - 项目类别:
Research Grant